ClinicalTrials.Veeva

Menu

Hepatitis C Patient Management and Family Health Education

C

China Liver Health

Status

Unknown

Conditions

Hepatitis C

Treatments

Behavioral: general health articles
Behavioral: HCV articles

Study type

Interventional

Funder types

Other

Identifiers

NCT03813498
IN-CN-987-5377

Details and patient eligibility

About

INTRODUCTION: Hepatitis C virus (HCV) is recognized as the leading cause of chronic liver disease worldwide. However, the screening rate and treatment rate of HCV-infected patients in China is low, which increases the burden of patients and the infection risk of their family members. WeChat, an instant messaging software, is used in a very high proportion in China. Health promotion based on WeChat public platform is a very convenient and effective way of health education. Therefore, this study plans to apply WeChat to conduct health intervention for HCV-infected patients. The objective is to explore the effect of We-media-based health promotion method on the detection rate and treatment rate of HCV-infected and their family members.

METHOD: Recruitment will be conduct in 10 hospitals in Jilin, Beijing, Henan and Anhui provinces. The subjects should be patients new diagnosed with hepatitis C at the hospital and aged 18 to 69. After signing the consent form, eligible participants were selected through the inclusion and exclusion criteria. 1000 participants will be recruited for the trial. After completing an baseline reseach by a online questionnaire, patients will be randomly assigned to receive a targeted short article on HCV weekly or a general health article with no mention of HCV. The intervention will last three months and a follow-up will be conduct at three month after the last intervention.

OUTCOMES: The primary outcome is antiviral therapy. The secondary outcomes are cognition and attitude towards hepatitis C, factors influencing antiviral therapy, time to first treatment and the compliance of treatment.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 69 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Permanent residents in the province
  • Ages 18-69 (inclusive)
  • Both blood anti-HCV test and HCV-RNA test is positive
  • Familiar with the use of mobile phones and WeChat
  • Informed consent and voluntary participation in the study

Exclusion criteria

  • Temporary staff who come to the city to work, travel or visit relatives, or those who will be living in other cities for a long time
  • Suffering from other serious diseases
  • Patients with mental disorder or memory disorder
  • Pregnant women or those who have a plan to prepare for pregnancy within one year
  • Refuse to participate in the investigation

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,000 participants in 2 patient groups

intervention group
Experimental group
Treatment:
Behavioral: HCV articles
control group
Other group
Treatment:
Behavioral: general health articles

Trial contacts and locations

0

Loading...

Central trial contact

Mingyang Li

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems